AI and Ethics,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 20, 2024
Abstract
In
reproductive
medicine,
current
research
into
the
use
of
artificial
intelligence
(AI)
to
improve
embryo
selection
has
been
met
with
enthusiasm.
Within
ethics,
previous
assessments
AI-assisted
have
focused,
for
example,
on
liability
gaps
or
risks
arising
from
opaque
decision-making.
I
argue
that
this
focus
ethical
issues
raised
by
AI
in
alone
is
incomplete
because
it
neglects
how
AI’s
convergence
other
innovative
technologies
raises
further
issues.
describe
acting
as
a
catalyst
social
disruption
human
reproduction
and
profound
change
morality.
The
result
improved
culture,
optimization
through
possibility
selecting
screened
embryo.
This
technological
interplay
creates
pull
towards
assisted
reproduction,
even
those
prospective
parents
who
can
reproduce
without
medical
assistance.
discussing
fictional
case
parents,
linked
moral
disruption.
manifests
itself
deep
uncertainty
about
legitimate
ways
procreating.
explain
rooted
technology-induced
concept
choice.
then
outline
debate
should
be
reframed
light
Human Reproduction,
Journal Year:
2024,
Volume and Issue:
39(5), P. 955 - 962
Published: March 29, 2024
Abstract
STUDY
QUESTION
Do
embryos
displaying
abnormal
cleavage
(ABNCL)
up
to
Day
3
have
compromised
live
birth
rates
and
neonatal
outcomes
if
full
blastulation
has
been
achieved
prior
transfer?
SUMMARY
ANSWER
ABNCL
is
associated
with
reduced
but
does
not
impact
once
achieved.
WHAT
IS
KNOWN
ALREADY?
It
widely
accepted
that
implantation
of
when
transferred
at
the
stage.
However,
evidence
scarce
in
literature
reporting
from
blastocysts
arising
embryos,
likely
because
they
are
ranked
low
priority
for
transfer.
DESIGN,
SIZE,
DURATION
This
retrospective
cohort
study
included
1562
consecutive
autologous
vitro
fertilization
cycles
(maternal
age
35.1
±
4.7
years)
performed
Fertility
North,
Australia
between
January
2017
June
2022.
Fresh
transfers
were
on
or
5,
remaining
cultured
6
before
vitrification.
A
total
6019
subject
blastocyst
culture,
a
subset
664
resulting
frozen
was
outcome
analyses
following
single
transfers.
PARTICIPANTS/MATERIALS,
SETTING,
METHODS
events
annotated
first
mitotic
division
3,
including
direct
(DC),
reverse
(RC)
<6
intercellular
contact
points
4-cell
stage
(<6ICCP).
For
DC
RC
combination,
ratios
affected
blastomeres
over
number
all
also
recorded.
All
pregnancies
followed
until
gestational
age,
birthweight,
sex
baby
being
MAIN
RESULTS
AND
THE
ROLE
OF
CHANCE
Full
showing
(19.5%),
(41.7%),
<6ICCP
(58.8%),
mixed
(≥2)
types
(26.4%)
lower
than
those
without
(67.2%,
P
<
0.01
respectively).
Subgroup
analysis
showed
declining
increasing
combined
DC/RC
8-cell
(66.2%
0
affected,
47.0%
0.25
27.4%
0.5
14.5%
0.75
7.7%
0.01).
had
achieved,
no
difference
detected
DC,
RC,
<6ICCP,
subsequent
(25.9%,
33.0%,
36.0%
versus
30.8%,
>
0.05,
respectively),
(38.7
1.6,
38.5
1.2,
38.3
3.5
1.8
weeks,
respectively)
birthweight
(3343.0
649.1,
3378.2
538.4,
3352.6
841.3
3313.9
509.6
g,
Multiple
regression
(logistic
linear
as
appropriate)
confirmed
differences
above
measures
after
accounting
potential
confounders.
LIMITATIONS,
REASONS
FOR
CAUTION
Our
limited
by
its
nature,
making
it
impossible
control
every
known
unknown
confounder.
Embryos
our
dataset,
surplus
selection
fresh
transfer,
may
represent
general
embryo
population.
WIDER
IMPLICATIONS
FINDINGS
findings
highlight
incremental
ABNCL,
depending
ratio
blastulation.
The
reassuring
imply
self-correction
mechanism
among
reaching
stage,
which
provides
valuable
guidance
clinical
practice
patient
counseling.
FUNDING/COMPETTING
INTEREST(S)
research
supported
an
Australian
Government
Research
Training
Program
(RTP)
Scholarship.
authors
report
conflict
interest.
TRIAL
REGISTRATION
NUMBER
N/A.
Information,
Journal Year:
2025,
Volume and Issue:
16(1), P. 18 - 18
Published: Jan. 2, 2025
The
introduction
of
artificial
intelligence
(AI)
in
embryo
selection
during
vitro
fertilization
presents
distinct
ethical
and
societal
challenges
compared
to
the
general
implementation
AI
healthcare.
This
narrative
review
examines
perspectives
potential
implications
implementing
AI-driven
selection.
literature
reveals
that
some
authors
perceive
as
an
extension
a
technocratic
paradigm
commodifies
embryos,
considering
any
methods
undermine
dignity
human
life.
Others,
instead,
contend
prioritizing
embryos
with
highest
viability
is
morally
permissible
while
cautioning
against
discarding
based
solely
on
unproven
assessments.
reviewed
identified
further
concerns
associated
this
technique,
including
possible
bias
criteria,
lack
transparency
black-box
algorithms,
risks
“machine
paternalism”
replacing
judgment,
privacy
issues
sensitive
fertility
data,
equity
access,
maintaining
human-centered
care.
These
findings,
along
results
only
randomized
controlled
trial
available,
suggest
clinical
practice
not
currently
scientifically
ethically
justified.
Implementing
deploying
responsible
would
be
feasible
if
raised
are
adequately
addressed.
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(9), P. 3127 - 3127
Published: April 30, 2025
Female
infertility
is
a
multifaceted
condition
affecting
millions
of
women
worldwide,
with
causes
ranging
from
hormonal
imbalances
and
genetic
predispositions
to
lifestyle
environmental
factors.
Traditional
diagnostic
approaches,
such
as
assays,
ultrasound
imaging,
testing,
often
require
extensive
time,
resources,
expert
interpretation.
In
recent
years,
artificial
intelligence
(AI)
has
emerged
transformative
tool
in
the
field
reproductive
medicine,
offering
advanced
capabilities
for
improving
accuracy,
efficiency,
personalization
diagnosis
treatment.
AI
technologies
demonstrate
significant
potential
analyzing
vast
complex
datasets,
identifying
hidden
patterns,
providing
data-driven
insights
that
enhance
clinical
decision-making
processes
assisted
(ART)
services.
This
narrative
review
explores
current
advancements
applications
female
diagnostics
therapeutics,
highlighting
key
technological
innovations,
their
implications,
existing
limitations.
It
also
discusses
future
revolutionizing
healthcare.
As
AI-based
continue
evolve,
integration
into
medicine
expected
pave
way
more
accessible,
cost-effective,
personalized
fertility
care.
Biology,
Journal Year:
2024,
Volume and Issue:
13(12), P. 988 - 988
Published: Nov. 28, 2024
Incorporating
artificial
intelligence
(AI)
into
in
vitro
fertilization
(IVF)
laboratories
signifies
a
significant
advancement
reproductive
medicine.
AI
technologies,
such
as
neural
networks,
deep
learning,
and
machine
promise
to
enhance
quality
control
(QC)
assurance
(QA)
through
increased
accuracy,
consistency,
operational
efficiency.
This
comprehensive
review
examines
the
effects
of
on
IVF
laboratories,
focusing
its
role
automating
processes
embryo
sperm
selection,
optimizing
clinical
outcomes,
reducing
human
error.
AI’s
data
analysis
pattern
recognition
capabilities
offer
valuable
predictive
insights,
enhancing
personalized
treatment
plans
increasing
success
rates
fertility
treatments.
However,
integrating
also
brings
ethical,
regulatory,
societal
challenges,
including
concerns
about
security,
algorithmic
bias,
human–machine
interface
decision-making.
Through
an
in-depth
examination
current
case
studies,
advancements,
future
directions,
this
manuscript
highlights
how
can
revolutionize
by
standardizing
processes,
improving
patient
advancing
precision
It
underscores
necessity
ongoing
research
ethical
oversight
ensure
fair
transparent
applications
sensitive
field,
assuring
responsible
use